RX Patient Tools
Use these quick guides before reading the article, or return to them when you need help preparing questions for a doctor.
CEDNIK syndrome is a very rare inherited condition that affects the brain, nerves, and skin at the same time. The name “CEDNIK” is an acronym that describes the main problems: CErebral dysgenesis (the brain does not form normally), pain, numbness, tingling, or weakness. সহজ বাংলা: স্নায়ুর ক্ষতি/সমস্যা।" data-rx-term="neuropathy" data-rx-definition="Neuropathy means nerve damage or irritation causing pain, numbness, tingling, or weakness. সহজ বাংলা: স্নায়ুর ক্ষতি/সমস্যা।">Neuropathy (damage or poor function of nerves), Ichthyosis (very dry, scaly skin), and palmoplantar Keratoderma (thick skin on the palms and soles). Many children also have small head size (microcephaly), major developmental delay, and low muscle tone. PubMed+2PMC+2
CEDNIK syndrome (often written as Cednik syndrome) is a very rare genetic condition that affects the brain, nerves, and skin. The name comes from the main problems seen in many patients: CErebral dysgenesis (the brain forms in an unusual way), D (development delay is common), Neuropathy (nerve damage), Ichthyosis (dry, scaly skin), and Keratoderma (thick skin on palms and soles). Most reports link it to biallelic (two-copy) changes in the SNAP29 gene, which can disturb how cells move and “package” important materials inside the body. There is no single cure, so treatment focuses on supporting daily function and treating symptoms early. J Clin Case Rep Med Images+4Genetic Disease Center+4PubMed+4
CEDNIK syndrome is usually caused by loss-of-function mutations in the SNAP29 gene (meaning the gene does not work properly), and it is most often autosomal recessive (a child typically inherits one nonworking copy from each parent). SNAP29 helps cells move and “traffic” small packages inside the cell (vesicles), which is important for healthy brain development and for normal skin barrier formation. PubMed+2PMC+2
Another names
Cerebral dysgenesis–pain, numbness, tingling, or weakness. সহজ বাংলা: স্নায়ুর ক্ষতি/সমস্যা।" data-rx-term="neuropathy" data-rx-definition="Neuropathy means nerve damage or irritation causing pain, numbness, tingling, or weakness. সহজ বাংলা: স্নায়ুর ক্ষতি/সমস্যা।">neuropathy–ichthyosis–(palmoplantar) keratoderma syndrome is the full expanded name and is often used in papers because it clearly lists the key body systems involved. PubMed+2Genome Japón+2
SNAP29-related disorder has been suggested as a broader name because some people with SNAP29 changes can have variable features (for example, the skin findings may be less obvious in some cases). PubMed
Types
There is no single, official “type” system used everywhere, but doctors often describe CEDNIK in these practical “types” based on genetics and presentation patterns reported in the medical literature. PMC+2PubMed+2
-
Classic CEDNIK (biallelic SNAP29 loss-of-function variants): The child has two nonworking SNAP29 copies (often truncating variants), leading to the typical mix of brain malformation, pain, numbness, tingling, or weakness. সহজ বাংলা: স্নায়ুর ক্ষতি/সমস্যা।" data-rx-term="neuropathy" data-rx-definition="Neuropathy means nerve damage or irritation causing pain, numbness, tingling, or weakness. সহজ বাংলা: স্নায়ুর ক্ষতি/সমস্যা।">neuropathy, ichthyosis, and palm/sole thickening. PubMed+2PMC+2
-
Compound heterozygous / mixed mechanism SNAP29-related disorder: One SNAP29 problem may be a small variant and the other may be a larger deletion affecting SNAP29, producing CEDNIK-range features with variability. Washington University Profiles+1
-
CEDNIK-like disease “unmasked” by 22q11.2 deletion plus SNAP29 variant on the other chromosome: Some people with a deletion that removes one SNAP29 copy can develop a similar picture if the remaining copy also has a damaging SNAP29 mutation. PMC
-
Variable-feature SNAP29-related disorder: Some reports highlight that skin findings, brain findings, and pain, numbness, tingling, or weakness. সহজ বাংলা: স্নায়ুর ক্ষতি/সমস্যা।" data-rx-term="neuropathy" data-rx-definition="Neuropathy means nerve damage or irritation causing pain, numbness, tingling, or weakness. সহজ বাংলা: স্নায়ুর ক্ষতি/সমস্যা।">neuropathy severity may differ between patients, so clinicians keep SNAP29 in mind even when not all 4 letters of “CEDNIK” are obvious early on. PubMed+1
Causes
-
Biallelic loss-of-function SNAP29 mutations: The core cause is having two SNAP29 copies that do not work, which disrupts important cell “traffic” processes. PubMed+1
-
A 1-base-pair deletion in SNAP29 (founder mutation in early families): The first described families had a shared small deletion that damaged SNAP29 function. PubMed
-
Homozygous nonsense variants (early stop signal): Some patients have an early “stop” in SNAP29 (nonsense change), which prevents a normal SNAP29 protein from being made. PMC
-
Homozygous frameshift variants: Some patients have a frameshift (a reading-frame change) that quickly produces a broken, shortened SNAP29 protein. PMC
-
Homozygous small insertions causing frameshift: Small added DNA letters can shift the reading frame and create a nonworking SNAP29 protein. PMC
-
Compound heterozygous SNAP29 variants: Some patients may have two different SNAP29 problems (one on each chromosome), still resulting in poor SNAP29 function overall. Washington University Profiles+1
-
A SNAP29 small variant plus a 22q11.2 deletion that removes the other SNAP29 copy: A deletion can remove one SNAP29 copy, and a damaging variant in the remaining copy can produce a SNAP29-deficiency syndrome. PMC+1
-
22q11.2 deletion syndrome with an additional SNAP29 mutation on the non-deleted chromosome: This “two-hit” situation has been linked to CEDNIK-like neuro-skin findings. PMC
-
Consanguinity (parents related by blood): Many reported families have parental relatedness, which increases the chance a child inherits the same rare SNAP29 mutation from both sides. PMC+1
-
Founder effect in certain populations/families: Some reports suggest a shared mutation in a community due to inheritance from a common ancestor. PMC
-
Reduced SNAP29 protein expression in tissues: In affected patients, SNAP29 expression can be decreased, which is linked to the disease mechanism. PubMed+1
-
Defective intracellular vesicle fusion: SNAP29 is part of vesicle fusion machinery, and disrupted fusion affects many cell functions important for brain and skin development. PubMed+2PMC+2
-
Abnormal lamellar granule maturation in skin: Skin cells normally use lamellar granules to deliver lipids and enzymes to build the skin barrier; SNAP29 loss disrupts this process. PubMed+1
-
Retention of lamellar contents and impaired barrier formation: When lamellar delivery fails, the outer skin barrier forms poorly, which contributes to ichthyosis and hyperkeratosis. PMC+1
-
Impaired endocytic recycling in patient cells: Studies of patient cells have shown disturbed recycling/trafficking pathways, supporting the trafficking-defect explanation. PMC
-
Neurodevelopmental brain malformations (cerebral dysgenesis) driven by SNAP29 dysfunction: Brain structure changes like cortical dysplasia and corpus callosum abnormalities are repeatedly reported with SNAP29 loss. PMC+1
-
Peripheral nerve involvement (pain, numbness, tingling, or weakness. সহজ বাংলা: স্নায়ুর ক্ষতি/সমস্যা।" data-rx-term="neuropathy" data-rx-definition="Neuropathy means nerve damage or irritation causing pain, numbness, tingling, or weakness. সহজ বাংলা: স্নায়ুর ক্ষতি/সমস্যা।">neuropathy) linked to SNAP29-related neurodegeneration/developmental damage: Many patients have clinical and test evidence of peripheral pain, numbness, tingling, or weakness. সহজ বাংলা: স্নায়ুর ক্ষতি/সমস্যা।" data-rx-term="neuropathy" data-rx-definition="Neuropathy means nerve damage or irritation causing pain, numbness, tingling, or weakness. সহজ বাংলা: স্নায়ুর ক্ষতি/সমস্যা।">neuropathy. PMC+2PMC+2
-
Neurocutaneous “shared origin” vulnerability: The skin and nervous system share embryonic roots, which helps explain why one gene defect can strongly affect both. PubMed
-
Phenotypic variability (not every patient shows the same severity early): Newer cohorts emphasize that features can be under-recognized or appear later, so SNAP29 deficiency can present in more than one clinical pattern. PubMed+1
-
Possible modifying effects from nearby genes when deletions are involved: When a deletion includes SNAP29 (and sometimes nearby genes), the overall picture can vary, which may change the “look” of the disorder. Washington University Profiles+1
Symptoms
-
Severe developmental delay: Many children take much longer to reach milestones like sitting, standing, speaking, and learning because the brain development is affected. PMC+2PMC+2
-
Intellectual disability: Long-term learning and thinking difficulties are common and often severe. PMC+1
-
Microcephaly (small head size): The head may become progressively small compared with age norms, reflecting impaired brain growth. PMC+2NCBI+2
-
Hypotonia (low muscle tone): Babies may feel “floppy,” have weak posture, and struggle with head and trunk control. NCBI+1
-
Peripheral pain, numbness, tingling, or weakness. সহজ বাংলা: স্নায়ুর ক্ষতি/সমস্যা।" data-rx-term="neuropathy" data-rx-definition="Neuropathy means nerve damage or irritation causing pain, numbness, tingling, or weakness. সহজ বাংলা: স্নায়ুর ক্ষতি/সমস্যা।">neuropathy: Nerve problems can cause weakness, reduced sensation, poor coordination, and loss of normal reflexes. NCBI+1
-
Areflexia (reduced reflexes): Doctors may find weak or absent tendon reflexes on exam, which supports pain, numbness, tingling, or weakness. সহজ বাংলা: স্নায়ুর ক্ষতি/সমস্যা।" data-rx-term="neuropathy" data-rx-definition="Neuropathy means nerve damage or irritation causing pain, numbness, tingling, or weakness. সহজ বাংলা: স্নায়ুর ক্ষতি/সমস্যা।">neuropathy. NCBI
-
Ichthyosis (dry, scaly skin): The skin can be rough and scaly because the outer barrier does not form normally. PubMed+2PMC+2
-
Palmoplantar keratoderma: The skin on palms and soles can become unusually thick and hard. NCBI+2PMC+2
-
Failure to thrive / poor weight gain: Feeding problems and high care needs can lead to low weight gain and poor growth. NCBI+2PMC+2
-
Feeding difficulties: Infants may struggle with sucking, swallowing, or coordinating feeding, sometimes needing special feeding support. PMC+1
-
Vision problems (including optic disc/optic nerve hypoplasia): Underdevelopment of the optic nerve head can reduce vision and affect eye tracking. NCBI+1
-
Hearing loss (sensorineural): Some patients have inner-ear or nerve-related hearing impairment. NCBI+1
-
Facial dysmorphism: Features such as a broad nasal bridge, eye-shape differences, or long face have been reported, though exact appearance varies. NCBI+1
-
Seizures (in some patients): Seizures are not in every child, but newer case series report them in a subset, showing variability. PubMed+1
-
Recurrent chest infections / aspiration pneumonia risk: Severe developmental disability and swallowing problems can increase the risk of aspiration and lung infections in some patients. PMC+1
Diagnostic tests
Physical exam
-
Head circumference measurement (occipital-frontal circumference): Tracking head size over time helps detect microcephaly and progressive slowing of head growth. NCBI+1
-
Full skin examination: A doctor looks closely for ichthyosis (dry scale) and palm/sole thickening, which are key clinical clues for this disorder. PMC+1
-
Neurologic exam (tone, strength, reflexes): Checking hypotonia and reduced reflexes can support peripheral neuropathy and neurodevelopmental involvement. NCBI+1
-
Eye exam (bedside + specialist exam): Clinicians check vision behaviors and refer to ophthalmology because optic disc/nerve hypoplasia has been reported. NCBI+1
-
Hearing evaluation screening: Because sensorineural hearing loss is reported, hearing testing is an important part of evaluation. NCBI+1
Manual tests
- Developmental assessment tools (example: Bayley or similar age-appropriate scales): Standard hands-on developmental testing measures motor, language, and cognitive delay severity. PMC+1
-
Manual muscle testing / functional motor assessment: A clinician or physiotherapist checks practical strength and motor function (head control, sitting balance, transfers). NCBI+1
-
Bedside sensory testing (light touch, vibration where possible): Simple exam techniques can suggest sensory neuropathy, especially in older children who can cooperate. NCBI+1
-
Swallowing/feeding bedside assessment: Careful observation of feeding and swallowing safety helps identify aspiration risk, which is clinically important in severe neurodevelopmental disorders. PMC+1
Lab and pathological tests
- Whole exome sequencing (WES): Many reports describe WES as a key confirmatory test that identifies the causative SNAP29 mutation in suspected CEDNIK. PMC
-
Targeted SNAP29 gene sequencing: If clinical suspicion is high, targeted sequencing can directly check SNAP29 for disease-causing variants. PubMed+1
-
Copy-number testing (chromosomal microarray or similar): This looks for deletions involving SNAP29 (including in the 22q11.2 region) that can contribute to SNAP29 deficiency. PMC+1
-
Parental carrier testing and family segregation testing: Testing parents helps confirm autosomal recessive inheritance and supports accurate genetic counseling. PMC+1
-
Skin biopsy with histopathology (and sometimes special studies): Because SNAP29 loss affects lamellar granules and skin barrier formation, skin biopsy can support the mechanism and help rule out other ichthyosis causes. PubMed+1
-
Basic supportive labs to assess complications (nutrition/infection/inflammation as clinically needed): While not specific for CEDNIK, clinicians often use general labs to evaluate failure to thrive and recurrent infections in severely affected children. NCBI+1
Electrodiagnostic tests
- Nerve conduction studies (NCS): NCS measures how fast and how strongly nerves carry signals and helps confirm peripheral neuropathy. PMC+1
-
Electromyography (EMG): EMG checks muscle electrical activity and can help clarify whether weakness is due to nerve damage. NCBI+1
-
Auditory brainstem response (ABR): ABR is an electrical hearing test that can detect sensorineural hearing pathway problems, which can occur in CEDNIK. NCBI+1
Imaging tests
- Brain MRI: MRI commonly shows structural brain differences (for example, corpus callosum problems and cortical malformations like polymicrogyria), supporting the “cerebral dysgenesis” part. PMC+2PMC+2
-
Spinal MRI when clinically indicated: Some recent reports describe additional findings (like tethered spinal cord in a case report), so spine imaging may be considered if symptoms suggest a spinal problem. PMC
Disclaimer: Each person’s journey is unique, treatment plan, life style, food habit, hormonal condition, immune system, chronic disease condition, geological location, weather and previous medical history is also unique. So always seek the best advice from a qualified medical professional or health care provider before trying any treatments to ensure to find out the best plan for you. This guide is for general information and educational purposes only. Regular check-ups and awareness can help to manage and prevent complications associated with these diseases conditions. If you or someone are suffering from this disease condition bookmark this website or share with someone who might find it useful! Boost your knowledge and stay ahead in your health journey. We always try to ensure that the content is regularly updated to reflect the latest medical research and treatment options. Thank you for giving your valuable time to read the article.
The article is written by Team RxHarun and reviewed by the Rx Editorial Board Members
Last Updated: December 15, 2025.
- Rare Diseases and Medical Genetics.[rxharun.com]
- i2023_IFPMA_Rare_Diseases_Brochure_28Feb2017_FINAL.[rxharun.com]
- the-UK-rare-diseases-framework.[rxharun.com]
- National-Recommendations-for-Rare-Disease-Health-Care-Summary.[rxharun.com]
- History of rare diseases and their genetic.[rxharun.com]
- health-care-and-rare-disorders.[rxharun.com]
- Rare Disease Registries.[rxharun.com]
- autoimmune-Rare-Genetic-Diseases.[rxharun.com]
- Rare Genetic Diseases.[rxharun.com]
- rare-disease-day.[rxharun.com]
- Rare_Disease_Drugs_e.[rxharun.com]
- fda-CDER-Rare-Diseases-Public-Workshop-Master.[rxharun.com]
- rare-and-inherited-disease-eligibility-criteria.[rxharun.com]
- FDA-rare-disease-list.pdf-rxharun.com1 Human-Gene-Therapy-for-Rare Diseases_Jan_2020fda.[rxharun.com]
- FDA-rare-disease-lists.[rxharun.com]
- 30212783fnl_Rare Disease.[rxharun.com]
- FDA-rare-disease-list.[rxharun.com]
- List of rare disease.[rxharun.com]
- Genome Res.-2025-Steyaert-755-68.[rxharun.com]
- uk-practice-guidelines-for-variant-classification-v4-01-2020.[rxharun.com]
- PIIS2949774424010355.[rxharun.com]
- hidden-costs-2016.[rxharun.com]
- B156_CONF2-en.[rxharun.com]
- IRDiRC_State-of-Play-2018_Final.[rxharun.com]
- IRDR_2022Vol11No3_pp96_160.[rxharun.com]
- from-orphan-to-opportunity-mastering-rare-disease-launch-excellence.[rxharun.com]
- Rare disease fda.[rxharun.com]
- England-Rare-Diseases-Action-Plan-2022.[rxharun.com]
- SCRDAC 2024 Report.[rxharun.com]
- CORD-Rare-Disease-Survey_Full-Report_Feb-2870-2.[rxharun.com]
- Stats-behind-the-stories-Genetic-Alliance-UK-2024.[rxharun.com]
- rare-and-inherited-disease-eligibility-criteria-v2.[rxharun.com]
- ENG_White paper_A4_Digital_FINAL.[rxharun.com]
- UK_Strategy_for_Rare_Diseases.[rxharun.com]
- MalaysiaRareDiseaseList.[rxharun.com]
- EURORDISCARE_FULLBOOKr.[rxharun.com]
- EMHJ_1999_5_6_1104_1113.[rxharun.com]
- national-genomic-test-directory-rare-and-inherited-disease-eligibilitycriteria-.[rxharun.com]
- be-counted-052722-WEB.[rxharun.com]
- RDI-Resource-Map-AMR_MARCH-2024.[rxharun.com]
- genomic-analysis-of-rare-disease-brochure.[rxharun.com]
- List-of-rare-diseases.[rxharun.com]
- RDI-Resource-Map-AFROEMRO_APRIL[rxharun.com]
- rdnumbers.[rxharun.com] .
- Rare disease atoz .[rxharun.com]
- EmanPublisher_12_5830biosciences-.[rxharun.com]
- https://www.ncbi.nlm.nih.gov/books/NBK208609/
- https://pmc.ncbi.nlm.nih.gov/articles/PMC6279436/
- https://rarediseases.org/rare-diseases/
- https://rarediseases.info.nih.gov/diseases
- https://en.wikipedia.org/w/index.php?title=Category:Rare_diseases
- https://en.wikipedia.org/wiki/List_of_genetic_disorders
- https://en.wikipedia.org/wiki/Category:Genetic_diseases_and_disorders
- https://medlineplus.gov/genetics/condition/
- https://geneticalliance.org.uk/support-and-information/a-z-of-genetic-and-rare-conditions/
- https://www.fda.gov/patients/rare-diseases-fda
- https://www.fda.gov/science-research/clinical-trials-and-human-subject-protection/support-clinical-trials-advancing-rare-disease-therapeutics-start-pilot-program
- https://accp1.onlinelibrary.wiley.com/doi/full/10.1002/jcph.2134
- https://www.mayoclinicproceedings.org/article/S0025-6196%2823%2900116-7/fulltext
- https://www.ncbi.nlm.nih.gov/mesh?
- https://www.rarediseasesinternational.org/working-with-the-who/
- https://ojrd.biomedcentral.com/articles/10.1186/s13023-024-03322-7
- https://www.rarediseasesnetwork.org/
- https://www.cancer.gov/publications/dictionaries/cancer-terms/def/rare-disease
- https://www.raregenomics.org/rare-disease-list
- https://www.astrazeneca.com/our-therapy-areas/rare-disease.html
- https://bioresource.nihr.ac.uk/rare
- https://www.roche.com/solutions/focus-areas/neuroscience/rare-diseases
- https://geneticalliance.org.uk/support-and-information/a-z-of-genetic-and-rare-conditions/
- https://www.genomicsengland.co.uk/genomic-medicine/understanding-genomics/rare-disease-genomics
- https://www.oxfordhealth.nhs.uk/cit/resources/genetic-rare-disorders/
- https://genomemedicine.biomedcentral.com/articles/10.1186/s13073-022-01026
- https://wikicure.fandom.com/wiki/Rare_Diseases
- https://www.wikidoc.org/index.php/List_of_genetic_disorders
- https://www.medschool.umaryland.edu/btbank/investigators/list-of-disorders/
- https://www.orpha.net/en/disease/list
- https://www.genetics.edu.au/SitePages/A-Z-genetic-conditions.aspx
- https://ojrd.biomedcentral.com/
- https://health.ec.europa.eu/rare-diseases-and-european-reference-networks/rare-diseases_en
- https://bioportal.bioontology.org/ontologies/ORDO
- https://www.orpha.net/en/disease/list
- https://www.fda.gov/industry/medical-products-rare-diseases-and-conditions
- https://www.gao.gov/products/gao-25-106774
- https://www.gene.com/partners/what-we-are-looking-for/rare-diseases
- https://www.genome.gov/For-Patients-and-Families/Genetic-Disorders
- https://geneticalliance.org.uk/support-and-information/a-z-of-genetic-and-rare-conditions/
- https://my.clevelandclinic.org/health/diseases/21751-genetic-disorders
- https://globalgenes.org/rare-disease-facts/
- https://www.nidcd.nih.gov/directory/national-organization-rare-disorders-nord
- https://byjus.com/biology/genetic-disorders/
- https://www.cdc.gov/genomics-and-health/about/genetic-disorders.html
- https://www.genomicseducation.hee.nhs.uk/doc-type/genetic-conditions/
- https://www.thegenehome.com/basics-of-genetics/disease-examples
- https://www.oxfordhealth.nhs.uk/cit/resources/genetic-rare-disorders/
- https://www.pfizerclinicaltrials.com/our-research/rare-diseases
- https://clinicaltrials.gov/ct2/results?recrs
- https://apps.who.int/gb/ebwha/pdf_files/EB116/B116_3-en.pdf
- https://stemcellsjournals.onlinelibrary.wiley.com/doi/10.1002/sctm.21-0239
- https://www.nibib.nih.gov/
- https://www.nei.nih.gov/
- https://oxfordtreatment.com/
- https://www.nidcd.nih.gov/health/https://consumer.ftc.gov/articles/
- https://www.nccih.nih.gov/health
- https://catalog.ninds.nih.gov/
- https://www.aarda.org/diseaselist/
- https://www.ninds.nih.gov/Disorders/Patient-Caregiver-Education/Fact-Sheets
- https://www.nibib.nih.gov/
- https://www.nia.nih.gov/health/topics
- https://www.nichd.nih.gov/
- https://www.nimh.nih.gov/health/topics
- https://www.nichd.nih.gov/
- https://www.niehs.nih.gov/
- https://www.nimhd.nih.gov/
- https://www.nhlbi.nih.gov/health-topics
- https://obssr.od.nih.gov/.
- https://www.nichd.nih.gov/health/topics
- https://rarediseases.info.nih.gov/diseases
- https://beta.rarediseases.info.nih.gov/diseases
- https://orwh.od.nih.gov/
